-
20 Years Since an EGFR Discovery, a Woman With Stage IV Lung Cancer Is Thriving
09 Aug 2024 00:33 GMT
… could alter outcomes for lung cancer patients with EGFR mutations. … by the brand name Gleevec) had reshaped the landscape … Until EGFR was implicated in lung cancer, medical oncologists were accustomed … is expressed in most lung cancers, so initially they gave …
-
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
22 Feb 2024 14:19 GMT
… lung cancer, precision oncology has achieved notable advances. Lung cancer, … development of imatinib (Gleevec; Novartis), a … Lung Cancer: From Broad Treatment to Individualized Approaches
Lung cancer … Immunotherapy in lung cancer. Transl Lung Cancer Res. 2014; …
-
Lung Cancer Surgery Market Worth USD 7.8 billion by 2030, Trends Analysis, Growth Rate, Share, Size, Revenue, Opportunities, Challenges, Key Drivers, Instrument, Procedure, Volume Data, Forecasts 2023-2030 | Exclusive Report by Delvens
15 May 2023 14:35 GMT
… of diagnosing and treating lung cancer Therapies for lung cancer can be broadly categorised … (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade, Zytiga, Xtandi, Others …
-
OncLive’s November Roundup of Key FDA Approvals in Oncology
03 Dec 2024 03:51 GMT
… previous therapy that included imatinib (Gleevec).
The agent was initially approved … with metastatic non–small cell lung cancer and MET exon 14 skipping …
-
Oncology Drugs, Diagnostics Approved by the FDA in November 2024
02 Dec 2024 16:48 GMT
… intolerant to prior therapy with Gleevec (imatinib).
An advantage of Danziten … carcinoma and non-small cell lung cancer.
MI Cancer Seek works by …
-
Advancing Equitable Access to Elevate Value-Based Cancer Care
21 Nov 2024 13:54 GMT
… lung cancer treatment actually start at screening. “We know that lung cancer … plus years ago imatinib [Gleevec] was approved. Since … first immunotherapy treatment for lung cancer. News release. … for patients with suspected lung cancers. Clinicaltrials.gov. …
-
Emerging TRK Inhibitors Are Explored Across Cancer Settings
07 Nov 2024 21:20 GMT
… when the FDA approved imatinib (Gleevec)— which targets the BCR- … ROS1-positive non–small cell lung cancer (NSCLC).9
NTRK fusions … patient with non–small cell lung cancer or a patient with … ROS1-positive non-small cell lung cancer. FDA. Updated November 16, …
-
OncLive’s October Roundup of Key FDA Approvals in Oncology
05 Nov 2024 16:40 GMT
… with resectable non–small cell lung cancer (NSCLC) and no EGFR mutations … a really exciting development in lung cancer, and specifically in early-stage … , which could have been imatinib (Gleevec), nilotinib (Tasigna), dasatinib (Sprycel), or …
-
Oncology Drugs Approved by the FDA in October 2024
01 Nov 2024 20:07 GMT
… diseases including non-small cell lung cancer, breast cancer, gastric and … -positive non-small cell lung cancer with no known EGFR … 3B non-small cell lung cancer. Opdivo significantly improved event … particularly in those treated with Gleevec, the rate of major …
-
Precision Medicine Unfolds in Oncology, Bearing Substantial Implications for the Future
30 Oct 2024 15:58 GMT
… oncogene addiction, with imatinib [Gleevec] for the treatment of … abnormalities that are identified. Lung cancer is a wonderful example … metastatic non–small cell lung cancer without finding out whether … to do this in lung cancer, where we find mutations …